TAIDOC TECHNOLOGY CORP (4736) - Cash Flow Conversion Efficiency
Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) has a cash flow conversion efficiency ratio of 0.024x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$238.93 Million ≈ $7.53 Million USD) by net assets (NT$9.96 Billion ≈ $313.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TAIDOC TECHNOLOGY CORP net asset quality index to measure how much of total assets are equity-financed.
TAIDOC TECHNOLOGY CORP - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how TAIDOC TECHNOLOGY CORP's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 4736 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
TAIDOC TECHNOLOGY CORP Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TAIDOC TECHNOLOGY CORP ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Jinfei Kaida Wheel Co Ltd
SHE:002863
|
0.040x |
|
Xpro India Limited
NSE:XPROINDIA
|
-0.003x |
|
Izmir Demir Celik Sanayi AS
IS:IZMDC
|
-0.021x |
|
Bafang Yunji Intl Co Ltd
TW:2753
|
0.123x |
|
Orion Engineered Carbons SA
NYSE:OEC
|
-0.045x |
|
Aurora Corp
TW:2373
|
-0.013x |
|
Braiin Limited Common Stock
NASDAQ:BRAI
|
N/A |
|
Valhi Inc
NYSE:VHI
|
-0.001x |
Annual Cash Flow Conversion Efficiency for TAIDOC TECHNOLOGY CORP (2009–2025)
The table below shows the annual cash flow conversion efficiency of TAIDOC TECHNOLOGY CORP from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see TAIDOC TECHNOLOGY CORP stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | NT$10.12 Billion ≈ $318.98 Million |
NT$853.39 Million ≈ $26.89 Million |
0.084x | +542.57% |
| 2024-09-30 | NT$9.52 Billion ≈ $300.01 Million |
NT$-181.37 Million ≈ $-5.71 Million |
-0.019x | -115.05% |
| 2023-09-30 | NT$9.26 Billion ≈ $291.71 Million |
NT$1.17 Billion ≈ $36.93 Million |
0.127x | -60.58% |
| 2022-09-30 | NT$9.99 Billion ≈ $314.89 Million |
NT$3.21 Billion ≈ $101.12 Million |
0.321x | +27.70% |
| 2021-09-30 | NT$7.63 Billion ≈ $240.53 Million |
NT$1.92 Billion ≈ $60.48 Million |
0.251x | -1.04% |
| 2020-09-30 | NT$6.62 Billion ≈ $208.59 Million |
NT$1.68 Billion ≈ $53.00 Million |
0.254x | +5.41% |
| 2019-09-30 | NT$4.51 Billion ≈ $142.12 Million |
NT$1.09 Billion ≈ $34.26 Million |
0.241x | +23.91% |
| 2018-09-30 | NT$4.02 Billion ≈ $126.75 Million |
NT$782.66 Million ≈ $24.66 Million |
0.195x | +18.66% |
| 2017-09-30 | NT$3.18 Billion ≈ $100.15 Million |
NT$521.21 Million ≈ $16.42 Million |
0.164x | -20.71% |
| 2016-09-30 | NT$3.08 Billion ≈ $96.90 Million |
NT$636.01 Million ≈ $20.04 Million |
0.207x | +18.63% |
| 2015-09-30 | NT$2.91 Billion ≈ $91.80 Million |
NT$507.88 Million ≈ $16.00 Million |
0.174x | -26.06% |
| 2014-09-30 | NT$2.49 Billion ≈ $78.42 Million |
NT$586.76 Million ≈ $18.49 Million |
0.236x | +32.93% |
| 2013-09-30 | NT$2.11 Billion ≈ $66.57 Million |
NT$374.74 Million ≈ $11.81 Million |
0.177x | +40.30% |
| 2012-09-30 | NT$1.96 Billion ≈ $61.74 Million |
NT$247.71 Million ≈ $7.80 Million |
0.126x | -28.47% |
| 2011-09-30 | NT$2.05 Billion ≈ $64.73 Million |
NT$363.06 Million ≈ $11.44 Million |
0.177x | +460.23% |
| 2010-09-30 | NT$2.27 Billion ≈ $71.41 Million |
NT$71.50 Million ≈ $2.25 Million |
0.032x | -88.51% |
| 2009-09-30 | NT$1.70 Billion ≈ $53.59 Million |
NT$466.80 Million ≈ $14.71 Million |
0.274x | -- |
About TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more